Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
QCP Capital: Geopolitical risk is the current biggest hidden danger, investors can lock in profits to prepare for the rise at the end of the year

QCP Capital: Geopolitical risk is the current biggest hidden danger, investors can lock in profits to prepare for the rise at the end of the year

Bitget2024/10/05 08:00

QCP Capital stated in its official channel that conflicts between Iran and Israel occurred this week. The market anticipates that Israel's retaliation will be more severe, targeting key infrastructure such as Iran's nuclear or oil facilities. In addition, non-farm data reflects a strong labor market, coupled with the possibility of further interest rate cuts later this year, which has boosted risk assets and allowed BTC to recover $62,000.

As we enter the fourth quarter, options market activity continues to grow with demand for December call options still increasing, highlighting the bullish view towards year-end. Although QCP Capital still believes macro data supports an "Uptober" outlook. However, before the U.S election geopolitical risks are the biggest hidden danger; QCP Capital prefers to lock in returns at current levels for safety and prepare for a rise at year-end.

3
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y

As traditional automakers cut back on their loss-making electric vehicle businesses, Tesla (TSLA.US) has regained more than half of the US electric vehicle market share.

智通财经2026/09/14 01:06
The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经2026/09/14 00:46
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas